1. Systematic Review and Network Meta-Analysis of Bevacizumab Plus First-Line Topotecan-Paclitaxel or Cisplatin-Paclitaxel Versus Non–Bevacizumab-Containing Therapies in Persistent, Recurrent, or Metastatic Cervical Cancer. Issue 6 (1st July 2017) Authors: Rosen, Virginia M.; Guerra, Ines; McCormack, Mary; Nogueira-Rodrigues, Angélica; Sasse, Andre; Munk, Veronica C.; Shang, Aijing Journal: International journal of gynecological cancer Issue: Volume 27:Issue 6(2017) Page Start: 1237 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Systematic Review and Network Meta-Analysis of Bevacizumab Plus First-Line Topotecan-Paclitaxel or Cisplatin-Paclitaxel Versus Non–Bevacizumab-Containing Therapies in Persistent, Recurrent, or Metastatic Cervical Cancer. Issue 6 (July 2017) Authors: Rosen, Virginia M.; Guerra, Ines; McCormack, Mary; Nogueira-Rodrigues, Angélica; Sasse, Andre; Munk, Veronica C.; Shang, Aijing Journal: International journal of gynecological cancer Issue: Volume 27:Issue 6(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗